Table 2

- Outcome measure comparison between on-site and telepharmacy in newly initiated warfarin patients.

Outcome	On-site	TELE	P-value
Time in therapeutic range	53.8 (33.5 to 70.4)^{^*}	50 (33.5 to 65.5)^{^*}	0.455^{^§}
Adverse anticoagulation outcome (n, %)
DVT	2 (1.8%)	1 (1.3%)	1
PE	0	0
Stroke	0	0
MI	0	0
Majorbleeding	2 (1.8%)	2 (2.6%)
Minor bleeding	1 (0.9%)	1 (1.3%)	1
Frequency of extreme INR
INR < 1.5^{^†}	1.16 (0.98 to 1.37)	1.43 (1.19 to 1.72)	0.383
INR > 4.5^{^†}	0.21 (0.14 to 0.32)	0.17 (0.09 to 0.31)	0.552
TTR ≥ 60 (n,%)	46 (40.4%)	23 (29.9%)	0.168

TELE:telepharmacy, DVT: deep vein thrombosis, PE: pulmonary embolism, MI: Myocardial infarction, INR: International normalized ratio

↵* Median (interquartile range),
↵^§ Adjusted using Bonferroni-Holm procedure for multiple comparisons.
↵^† The 6-month incidence rate per patient, along with its corresponding 95% confidence interval, was estimated using a Poisson log-linear regression model.